NCT00252564 Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00250029 Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen Status COMPLETED Phase NA
NCT00242190 Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00238849 Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC. Status UNKNOWN Phase PHASE2
NCT00227747 Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer Status COMPLETED Phase PHASE3
NCT00227617 Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors Status TERMINATED Phase PHASE2/PHASE3
NCT00226941 A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00222469 Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00217737 Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00217711 Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE1/PHASE2
NCT00217581 Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer Status COMPLETED Phase PHASE2
NCT00216073 Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT00216021 Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00215982 Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00209703 Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00199797 Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00193609 Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site Status COMPLETED Phase PHASE2
NCT00193219 Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00193128 Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00192088 A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma Status COMPLETED Phase PHASE2